← SynDRA
Docosahexaenoic acid ethyl ester
SynDRA canonical compound SYN1362072 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Mechanism of action | omega 3 fatty acid stimulant |
|---|
| Indication | hypertriglyceridemia |
|---|
| Disease area | endocrinology |
|---|
ATC classes
- C10A · LIPID MODIFYING AGENTS, PLAIN
Cross-references
Synonyms
- Ethyl docosahexaenoate
- Cervonic acid ethyl ester
- Incromega DHA 700ESR
- 7PO7G8PA8M
- MATK-90
- Et-DHA
- RefChem:1083934
- DTXCID801510583
- DHA ethyl ester
- cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester
- (4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid ethyl ester
- C24H36O2
- Ethyl cis-4,7,10,13,16,19-Docosahexaenoate
- UNII-7PO7G8PA8M
- MFCD00673477
- DOCONEXENT ETHYL ESTER
- Curator_000015
- SCHEMBL442556
- ethyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate
- orb2281188
- CHEBI:84945
- Docosahexaenoic acid ethyl ester CRS
- FD22578
- AC-33766
- BP-29834
- BS-45078
- HY-107343
- CS-0028185
- E84073
- T41321
- DOCOSAHEXAENOIC ACID ETHYL ESTER [MART.]
- DOCOSAHEXAENOIC ACID ETHYL ESTER [USP-RS]
- DOCOSAHEXAENOIC ACID ETHYL ESTER [WHO-DD]
- F852143
- BRD-K61937613-001-01-1
- ethyl (all-z)-4,7,10,13,16,19-docosahexaenoate
- ethyl all-cis-docosa-4,7,10,13,16,19-hexaenoate
- (all-Z)-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester
- 4,7,10,13,16,19-DOCOSAHEXAENOIC ACID, ETHYL ESTER, (ALL-Z)-
Reported adverse events
- Dyspepsia
- Constipation
- Eructation
- Pruritus
- Rash
- Alopecia
- Angina pectoris
- Arrhythmia
- Arthralgia
- Asthma
- Back pain
- Cataract
Look up Docosahexaenoic acid ethyl ester in the interactive SynDRA portal →